table of content
1 Study Coverage
1.1 Chronic Heart Failure (CHF) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Chronic Heart Failure (CHF) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anti-clotting (Aspirin)
1.2.3 Antiplatelet Medicines (Clopidogrel, Prasugrel, and Ticagrelor)
1.2.4 Anticoagulant Medicines (Warfarin)
1.2.5 Blood Pressure Maintaining Agents (Angiotensin Converting Enzyme (ACE) Inhibitors)
1.2.6 Angiotensin II Receptor Blockers (ARB)
1.2.7 Statins
1.2.8 Diuretics
1.2.9 Nitrates
1.3 Market by Application
1.3.1 Global Chronic Heart Failure (CHF) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Chronic Heart Failure (CHF) Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Chronic Heart Failure (CHF) Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Chronic Heart Failure (CHF) Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Chronic Heart Failure (CHF) Drugs Sales by Region
2.4.1 Global Chronic Heart Failure (CHF) Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Chronic Heart Failure (CHF) Drugs by Region (2023-2028)
2.5 Global Chronic Heart Failure (CHF) Drugs Revenue by Region
2.5.1 Global Chronic Heart Failure (CHF) Drugs Revenue by Region (2017-2022)
2.5.2 Global Chronic Heart Failure (CHF) Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Chronic Heart Failure (CHF) Drugs Sales by Manufacturers
3.1.1 Global Top Chronic Heart Failure (CHF) Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Chronic Heart Failure (CHF) Drugs in 2021
3.2 Global Chronic Heart Failure (CHF) Drugs Revenue by Manufacturers
3.2.1 Global Chronic Heart Failure (CHF) Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Chronic Heart Failure (CHF) Drugs Revenue in 2021
3.3 Global Chronic Heart Failure (CHF) Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Chronic Heart Failure (CHF) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Chronic Heart Failure (CHF) Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Chronic Heart Failure (CHF) Drugs Sales by Type
4.1.1 Global Chronic Heart Failure (CHF) Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Chronic Heart Failure (CHF) Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Type (2017-2028)
4.2 Global Chronic Heart Failure (CHF) Drugs Revenue by Type
4.2.1 Global Chronic Heart Failure (CHF) Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Chronic Heart Failure (CHF) Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Chronic Heart Failure (CHF) Drugs Price by Type
4.3.1 Global Chronic Heart Failure (CHF) Drugs Price by Type (2017-2022)
4.3.2 Global Chronic Heart Failure (CHF) Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Chronic Heart Failure (CHF) Drugs Sales by Application
5.1.1 Global Chronic Heart Failure (CHF) Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Chronic Heart Failure (CHF) Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028)
5.2 Global Chronic Heart Failure (CHF) Drugs Revenue by Application
5.2.1 Global Chronic Heart Failure (CHF) Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Chronic Heart Failure (CHF) Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Chronic Heart Failure (CHF) Drugs Price by Application
5.3.1 Global Chronic Heart Failure (CHF) Drugs Price by Application (2017-2022)
5.3.2 Global Chronic Heart Failure (CHF) Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Chronic Heart Failure (CHF) Drugs Market Size by Type
6.1.1 North America Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028)
6.1.2 North America Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2028)
6.2 North America Chronic Heart Failure (CHF) Drugs Market Size by Application
6.2.1 North America Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028)
6.2.2 North America Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2028)
6.3 North America Chronic Heart Failure (CHF) Drugs Market Size by Country
6.3.1 North America Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2028)
6.3.2 North America Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Chronic Heart Failure (CHF) Drugs Market Size by Type
7.1.1 Europe Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028)
7.1.2 Europe Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2028)
7.2 Europe Chronic Heart Failure (CHF) Drugs Market Size by Application
7.2.1 Europe Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028)
7.2.2 Europe Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2028)
7.3 Europe Chronic Heart Failure (CHF) Drugs Market Size by Country
7.3.1 Europe Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2028)
7.3.2 Europe Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Chronic Heart Failure (CHF) Drugs Market Size by Type
8.1.1 Asia Pacific Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Chronic Heart Failure (CHF) Drugs Market Size by Application
8.2.1 Asia Pacific Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Chronic Heart Failure (CHF) Drugs Market Size by Region
8.3.1 Asia Pacific Chronic Heart Failure (CHF) Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Chronic Heart Failure (CHF) Drugs Market Size by Type
9.1.1 Latin America Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028)
9.1.2 Latin America Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2028)
9.2 Latin America Chronic Heart Failure (CHF) Drugs Market Size by Application
9.2.1 Latin America Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028)
9.2.2 Latin America Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2028)
9.3 Latin America Chronic Heart Failure (CHF) Drugs Market Size by Country
9.3.1 Latin America Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2028)
9.3.2 Latin America Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Chronic Heart Failure (CHF) Drugs Market Size by Type
10.1.1 Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Chronic Heart Failure (CHF) Drugs Market Size by Application
10.2.1 Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Chronic Heart Failure (CHF) Drugs Market Size by Country
10.3.1 Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Overview
11.1.3 Abbott Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Johnson & Johnson Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Johnson & Johnson Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Stanley Pharmaceuticals
11.4.1 Stanley Pharmaceuticals Corporation Information
11.4.2 Stanley Pharmaceuticals Overview
11.4.3 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Stanley Pharmaceuticals Recent Developments
11.5 New Haven Pharmaceuticals, Inc.
11.5.1 New Haven Pharmaceuticals, Inc. Corporation Information
11.5.2 New Haven Pharmaceuticals, Inc. Overview
11.5.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 New Haven Pharmaceuticals, Inc. Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 GlaxoSmithKline plc
11.7.1 GlaxoSmithKline plc Corporation Information
11.7.2 GlaxoSmithKline plc Overview
11.7.3 GlaxoSmithKline plc Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GlaxoSmithKline plc Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GlaxoSmithKline plc Recent Developments
11.8 Novartis International AG
11.8.1 Novartis International AG Corporation Information
11.8.2 Novartis International AG Overview
11.8.3 Novartis International AG Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Novartis International AG Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis International AG Recent Developments
11.9 Biovail Corporation
11.9.1 Biovail Corporation Corporation Information
11.9.2 Biovail Corporation Overview
11.9.3 Biovail Corporation Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Biovail Corporation Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Biovail Corporation Recent Developments
11.10 Bristol-Myers Squibb Company
11.10.1 Bristol-Myers Squibb Company Corporation Information
11.10.2 Bristol-Myers Squibb Company Overview
11.10.3 Bristol-Myers Squibb Company Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Bristol-Myers Squibb Company Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bristol-Myers Squibb Company Recent Developments
11.11 Symplmed Pharmaceuticals
11.11.1 Symplmed Pharmaceuticals Corporation Information
11.11.2 Symplmed Pharmaceuticals Overview
11.11.3 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Symplmed Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Chronic Heart Failure (CHF) Drugs Industry Chain Analysis
12.2 Chronic Heart Failure (CHF) Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Chronic Heart Failure (CHF) Drugs Production Mode & Process
12.4 Chronic Heart Failure (CHF) Drugs Sales and Marketing
12.4.1 Chronic Heart Failure (CHF) Drugs Sales Channels
12.4.2 Chronic Heart Failure (CHF) Drugs Distributors
12.5 Chronic Heart Failure (CHF) Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Chronic Heart Failure (CHF) Drugs Industry Trends
13.2 Chronic Heart Failure (CHF) Drugs Market Drivers
13.3 Chronic Heart Failure (CHF) Drugs Market Challenges
13.4 Chronic Heart Failure (CHF) Drugs Market Restraints
14 Key Findings in The Global Chronic Heart Failure (CHF) Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
